11.71
Tyra Biosciences Inc stock is traded at $11.71, with a volume of 242.32K.
It is up +0.09% in the last 24 hours and up +13.80% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$11.70
Open:
$11.72
24h Volume:
242.32K
Relative Volume:
0.83
Market Cap:
$621.68M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-7.2733
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+9.13%
1M Performance:
+13.80%
6M Performance:
-11.09%
1Y Performance:
-46.21%
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TYRA
Tyra Biosciences Inc
|
11.71 | 576.14M | 0 | -83.74M | -64.98M | -1.61 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-21-25 | Resumed | Piper Sandler | Overweight |
Jan-07-25 | Initiated | UBS | Buy |
Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
Aug-15-24 | Initiated | Piper Sandler | Overweight |
Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
Jun-30-23 | Initiated | Wedbush | Outperform |
Feb-03-23 | Initiated | Oppenheimer | Outperform |
Jun-23-22 | Initiated | H.C. Wainwright | Buy |
Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
Oct-11-21 | Initiated | BofA Securities | Buy |
Oct-11-21 | Initiated | Cowen | Outperform |
Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Can trapped investors hope for a rebound in Tyra Biosciences Inc.2025 Pullback Review & Reliable Breakout Forecasts - Newser
Tyra Biosciences Announces Participation at Upcoming Investor Events - 富途牛牛
RSI Reset May Fuel Rebound in Tyra Biosciences Inc.July 2025 Patterns & Technical Confirmation Alerts - thegnnews.com
Tyra Biosciences Inc. stock chart pattern explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Can Tyra Biosciences Inc. hit a new high this monthWeekly Volume Report & Technical Pattern Recognition Alerts - Newser
Volume spikes in Tyra Biosciences Inc. stock – what they mean2025 Institutional Moves & Weekly Breakout Stock Alerts - Newser
Live market analysis of Tyra Biosciences Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - Newser
Real time social sentiment graph for Tyra Biosciences Inc.Take Profit & Weekly High Return Forecasts - Newser
Using Bollinger Bands to evaluate Tyra Biosciences Inc.July 2025 Highlights & Capital Protection Trade Alerts - Newser
Will Tyra Biosciences Inc. stock benefit from AI tech trendsPortfolio Update Summary & Daily Stock Momentum Reports - Newser
How sentiment analysis helps forecast Tyra Biosciences Inc.Portfolio Return Report & Real-Time Stock Movement Alerts - Newser
How to recover losses in Tyra Biosciences Inc. stock2025 Historical Comparison & Stock Portfolio Risk Management - Newser
Is it too late to sell Tyra Biosciences Inc.Quarterly Profit Report & Free Real-Time Volume Trigger Notifications - Newser
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Ranking Tyra Biosciences Inc. among high performing stocks via toolsJuly 2025 Retail & Daily Chart Pattern Signals - Newser
Is Tyra Biosciences Inc. meeting your algorithmic filter criteriaWeekly Investment Recap & Fast Entry Momentum Trade Alerts - Newser
How Tyra Biosciences Inc. stock performs during market volatilityQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
What machine learning models say about Tyra Biosciences Inc.2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Using Ichimoku Cloud for Tyra Biosciences Inc. technicalsPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
What moving averages say about Tyra Biosciences Inc.Rate Cut & Community Trade Idea Sharing - Newser
FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight - PR Newswire
What the charts say about Tyra Biosciences Inc. today2025 Price Momentum & Consistent Income Trade Ideas - Newser
Will a bounce in Tyra Biosciences Inc. offer an exitEarnings Growth Summary & Weekly High Conviction Ideas - Newser
What recovery options are there for Tyra Biosciences Inc.Portfolio Performance Summary & Risk Controlled Swing Alerts - Newser
Wall Street Analysts See a 178.82% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High? - sharewise.com
Developing predictive dashboards with Tyra Biosciences Inc. dataJuly 2025 Trends & Precise Swing Trade Entry Alerts - Newser
Is Tyra Biosciences Inc. showing signs of accumulationMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Volatility clustering patterns for Tyra Biosciences Inc.Weekly Trade Recap & High Accuracy Trade Alerts - Newser
How to manage a losing position in Tyra Biosciences Inc.Trade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
Volume Surge May Signal Institutional Interest in Tyra Biosciences Inc.July 2025 WrapUp & Long-Term Growth Portfolio Plans - newsyoung.net
Can Tyra Biosciences Inc. ride the EV waveTrend Reversal & Capital Efficient Trading Techniques - kangso.co.kr
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tyra Biosciences Inc Stock (TYRA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
KAPLAN GILLA | Director |
Jun 17 '25 |
Sale |
10.35 |
10 |
104 |
37,799 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):